There are bargains to be had in this market: Stock picker

CNBC's Kelly Evans discusses markets after stocks stumbled after a report showed that Gilead's Remdesivir "flopped" in trials with Kim Forrest of Bokeh Capital Partners and Brad McMillan of Commonwealth Financial Network.